Contact
searchSearch
HMP Global

News

News
FDA Proposes New Patient Medication Information Guide to Improve Patient Understanding and Adherence
04/26/2024
The FDA proposed introducing a Patient Medication Information (PMI), in addition to the Medication Guide, to provide clear and concise details about prescription medications to improve patient understanding and adherence, ultimately reducing...
The FDA proposed introducing a Patient Medication Information (PMI), in addition to the Medication Guide, to provide clear and concise details about prescription medications to improve patient understanding and adherence, ultimately reducing...
The FDA proposed introducing a...
04/26/2024
Pharmacy Learning Network
News
Subpotent Antibiotic Pulled
04/24/2024
Lupin Pharmaceuticals Inc. is recalling 26,352 bottles of rifampin capsules because the drug is subpotent, according to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Lupin Pharmaceuticals Inc. is recalling 26,352 bottles of rifampin capsules because the drug is subpotent, according to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Lupin Pharmaceuticals Inc. is...
04/24/2024
Pharmacy Learning Network
News
Skin Med Recalled for Superpotency
04/24/2024
Teva Pharmaceuticals USA Inc. is recalling a single lot of isotretinoin capsules over concerns of superpotency. According to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, results from 3-month stability testing...
Teva Pharmaceuticals USA Inc. is recalling a single lot of isotretinoin capsules over concerns of superpotency. According to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, results from 3-month stability testing...
Teva Pharmaceuticals USA Inc. is...
04/24/2024
Pharmacy Learning Network
News
OTC Acid Reducer Recalled
04/18/2024
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter lansoprazole delayed-release capsules are being recalled because of deviations from Current Good Manufacturing Practice regulations, according to the April 17, 2024, US Food and Drug Administration (FDA)...
A single lot of over-the-counter...
04/18/2024
Pharmacy Learning Network
News
Three Firms Recall Injections for Sterility Concerns
04/17/2024
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and Drug Administration (FDA) Enforcement Report included 4 drug recalls across 3 firms because of a lack of assurance of product sterility.
The April 10, 2024, US Food and...
04/17/2024
Pharmacy Learning Network
News
FDA Collaborates With AbbVie to Track Down Counterfeit Botox Injections
04/16/2024
On Tuesday, April 16, the FDA alerted consumers and health care professionals alike to widely distributed counterfeit versions of Botox that were administered to consumers across Colorado, Nebraska, Illinois, Florida, Kentucky, New York,...
On Tuesday, April 16, the FDA alerted consumers and health care professionals alike to widely distributed counterfeit versions of Botox that were administered to consumers across Colorado, Nebraska, Illinois, Florida, Kentucky, New York,...
On Tuesday, April 16, the FDA...
04/16/2024
Pharmacy Learning Network
News
Incorrect Package Insert Prompts Recall
04/16/2024
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is recalling more than 2500 vials of cyclophosphamide for injection because of an error in the package insert.
X-Gen Pharmaceuticals Inc. is...
04/16/2024
Pharmacy Learning Network
News
Resmetirom Superior to Placebo for NASH Resolution and Liver Fibrosis Reduction
04/10/2024
In adults with nonalcoholic steatohepatitis (NASH), resmetirom was superior to placebo for the outcomes of NASH resolution and improvement in liver fibrosis by at least one stage, according to a study published in The New England Journal of...
In adults with nonalcoholic steatohepatitis (NASH), resmetirom was superior to placebo for the outcomes of NASH resolution and improvement in liver fibrosis by at least one stage, according to a study published in The New England Journal of...
In adults with nonalcoholic...
04/10/2024
Pharmacy Learning Network
News
More than 30 Injection Products Recalled for Sterility Concerns
04/09/2024
SCA Pharmaceuticals is recalling 32 injection drug products in bags, syringes, and cassettes due to a lack of assurance of sterility, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
SCA Pharmaceuticals is recalling 32 injection drug products in bags, syringes, and cassettes due to a lack of assurance of sterility, according to the April 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.
SCA Pharmaceuticals is recalling...
04/09/2024
Pharmacy Learning Network
News
Outcomes Worse in Adults Hospitalized With RSV than Influenza
04/09/2024
US adults hospitalized with respiratory syncytial virus (RSV) were more likely to have cardiopulmonary conditions, undergo longer hospital stays, and need mechanical ventilation compared with those hospitalized with influenza, according to a...
US adults hospitalized with respiratory syncytial virus (RSV) were more likely to have cardiopulmonary conditions, undergo longer hospital stays, and need mechanical ventilation compared with those hospitalized with influenza, according to a...
US adults hospitalized with...
04/09/2024
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use